6719 abstracts found.



Results filter

The incidence of non-ovarian cancers in women with elevated CA125 levels in General Practice

Year:

Session type:

Garth Funston1,Willie Hamilton2,Gary Abel2,Emma Crosbie3,Brian Rous4,Fiona Walter5

1Department of Public Health and Primary Care, University of Cambridge,2University of Exeter,3Gynaecological Oncology Research Group, Division of Cancer Sciences, University of Manchester,4National Cancer Registration and Analysis Service, Public Health England,5Department of Public Health and Primary Care, University of Cambridge, Cambridge


Non-invasive methylation test to detect cervical pre-cancer in self-collected vaginal and urine specimens

Year:

Session type:

Belinda Nedjai1,Caroline Reuter1,Toni Hollingworth1,Janet Austin1,Louise Cadman1,Jack Cuzick1,Attila Lorincz1

1Queen Mary University of London, London, UK


Prospective clinical validation of novel serum biomarker test for the identification of patients at risk of brain tumour.

Year:

Session type:

Paul Brennan1,Holly Butler2,Mark Hegarty3,Ben Smith2,David Palmer2,Michael Jenkinson4,Matt Baker5

1university of edinburgh,2University of Strathclyde,3Clin Spex Dx Ltd,4University of Liverpool,5university of Strathclyde


ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer (NSCLC)

Year:

Session type:

Claire Lawless1,Kathleen Boyd2,Corinne Faivre-Finn3,John Fenwick4,Tom Haswell5,David Landau6,Jason Lester7,Joe Maguire8,Elaine McCartney1,Jim Paul1,Matthew Hatton9

1CRUK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK,2Health Economics & Health Technology Assessment, University of Glasgow, Glasgow, UK,3The Christie NHS Foundation Trust, Manchester, UK,4Gray Institute of Radiation Oncology & Biology, University of Oxford, Oxford, UK,5West of Scotland Cancer Research Consumer Panel, Glasgow, UK,6Guys & St Thomas NHS Trust, London, UK,7Velindre Cancer Centre, Cardiff, UK,8Clatterbridge Cancer Centre, Liverpool, UK,9Weston Park Hospital, Sheffield, UK


Making Big Data available: Informatics Infrastructure supporting the MRC/CRUK funded Stratification in COloRecTal Cancer (S-CORT) programme

Year:

Session type:

Andrew Blake1,Enric Domingo1,Michael Youdell1,Susan Richman2,Peter Stewart3,Celina Whalley4,Clare Hardy5,Katerina Chatazipli5,on behalf of S-CORT Consortium6,Tim Maughan1
1University of Oxford,2University of Leeds,3Queens University Belfast,4University of Birmingham,5Wellcome Trust Sanger Institute,6S-CORT Consortium

CEBOC: Evaluation of the safety of Cediranib in the prevention of Bowel perforation in platinum-resistant Ovarian Cancer

Year:

Session type:

Ann White1,Andrew Clamp2,Robert Morgan2,Dilly Goonetilleke3,Angela Casbard4,Tracie-Ann Madden4,Jennifer Swettenham4,Alkesh Patel2,Charlotte Wilhelm-Benartzi4,Catherine Rogers2,Gordon Jayson2
1,2The Christie NHS Foundation Trust,3The University of Manchester,4Cardiff University

Chemotherapy-Induced Peripheral Neuropathy: Incidence and Effect on Quality of Life

Year:

Session type:

Cheney Wong1
1University of Manchester

Stratification in COloRectal cancer: from biology to Treatment prediction (S:CORT) – Transcriptional profiling of RNA from FFPE tissue

Year:

Session type:

Keara Redmond1,Susan Richman2,Andrew Blake3,Enric Domingo3,Michael Youdell3,Tim Maughan3,Mark Lawler1,Philip Dunne1
1Queen's University Belfast,2University of Leeds,3University of Oxford

Phase II randomised control trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer

Year:

Session type:

Lucy Hackshaw-McGeagh1,Chris Penfold1,Ellie Shingler2,Athene Lane2,Richard Martin1
1University of Bristol,2University of bristol

Discussions about Escalation and DNACPR in the Acute Oncology Service: a Quality Improvement Project

Year:

Session type:

Rebecca Squires1,Joseph Page1,Katherine Belfield1,Jason Chai1,Esther Hindley1
1University Hospitals Bristol NHS Foundation Trust

ASSESSMENT & MANAGEMENT OF CANCER RELATED FATIGUE ON THE LIVES OF PATIENTS

Year:

Session type:

Ishrat Rafique Eshita1,N/a N/a2,N/a N/a2,N/a N/a3,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2,N/a N/a2
1National Institute of Preventive & Social Medicine, Bangladesh,2n/a,31987

Pelvic Radiation Disease – what the doctor didn’t tell you.

Year:

Session type:

Tim Ward1,Andrew Brunskill2
1Pelvic Radiation Disease Association/ NCR Consumer CTRad WS2,2Pelvic Radiation Disease Association

Chronic exposure to the novel PARP inhibitor niraparib (ZEJULA®), in contrast to olaparib, limits the impact of chemotherapy-induced multidrug resistance in ovarian cancer

Year:

Session type:

Gillian Smith1,Aparajitha Vaidyanathan1,Amber McWhirter1,Lynne Sawers1,Susan Bray1,Kaiming Sun2,Jing Yu Wang2,Michelle Ferguson3
1University of Dundee,2TESARO,3NHS Tayside

Difficulties In Providing Palliative Care In Rural India (West Bengal) – Experience Of An NGO

Year:

Session type:

Nabanita Mandal1,Aditya Manna2
1Narikeldaha Prayas,2MAS Clinic & Hospital

Assessing Food Related Anxiety in patients with Lung Cancer

Year:

Session type:

Iain Phillips1,Hannah Appleton2,Zari Bhatti2,Angus Lawson2,Adam Tobias2,Juliet Tyndall2,Lucas Watson2,Colin Barrie3
1Royal Surrey County Hospital,2University of Edinburgh,3Edinburgh Cancer Centre, Western General Hospital, Edinburgh

Expression Levels of hsa-miR-590-3p in Hepatocellular Carcinoma and Osteosarcoma Cell Lines and its Downstream Target Genes

Year:

Session type:

Mennatallah Elfar1,Asma Amleh2
1Generations Labs,2The American University in Cairo

Acupuncture for the treatment of paraneoplastic night sweats.

Year:

Session type:

Visweswaran Ramasamy1
1John Taylor hospice

Could novel inhibition of acid ceramidase with LCL521 have a translatable role for locally advanced rectal cancer?

Year:

Session type:

Rachael Clifford1,Naren Govindarajah1,David Bowden1,Paul Sutton1,Aiping Bai2,Zdzislaw Szulc2,Besim Ogretmen2,Jason Parsons1,Dale Vimalachandran3
1Institute of Cancer Medicine, The University of Liverpool,2Medical University of South Carolina,3The Countess of Chester Hospital

3-D cell culture models for detection of biomarker indicating anti-EGFR antibody resistance in colon cancer patients

Year:

Session type:

Jens Hahne1,Andrea Lampis1,Michele Ghidini2,Margherita Ratti2,Massimiliano Salati1,Chiara Senti2,Rodolfo Passalacqua2,Luciano Cascione3,Chiara Braconi1,Owen Sansom4,Matteo Fassan5,Nicola Valeri1
1The Institute of Cancer Research London,2Istituti Ospitalieri di Cremona,3Institute of Cancer Research Belinzola,4The Beatson Institute for Cancer Research,5University of Padua

Palliative radiotherapy to the oesophagus: Less is just as good.

Year:

Session type:

Shefali Parikh1,Oliver Coen1,Rebecca Goody1,Ganesh Radhakrishna2,Paul Hatfield1,Mohan Hingorani1
1Leeds Cancer Centre,2The Christie, Manchester

Mutation analysis of Beta2-Microglobulin identifies a subset of deficient mismatch repair (dMMR) colorectal cancers which are protected from disease recurrence.

Year:

Session type:

Susan Richman1,Paul Barrow2,Andrew Wallace3,Kelly Handley4,Gordon Hutchins5,David Kerr6,Laura Magill4,Gareth Evans3,Richard Gray6,Phil Quirke5,James Hill2
1Leeds Teaching Hospitals NHS Trust,2Manchester Royal Infirmary,3Central Manchester University Hospitals NHS Trust,4University of Birmingham,5University of Leeds,6University of Oxford

What accessible interventions are available to support cancer survivors to improve their quality of life?

Year:

Session type:

Nikki Hayward1,Sally Markwell2
1Oxford University Hospitals NHS Trust, Oxford, UK,2Oxford Brookes university

A national audit of cardiopulmonary resuscitation discussions with patients admitted to acute oncology ward

Year:

Session type:

Isabel Tol1,Robert Watson2,Elspeth Cumber3,Ami Sabharwal4,Andrew Protheroe4,Ashling Lillis3,Daphne Nakakande5,Silvana Wijaya5,Catherine Turberfield5,Abdul Badran5,Safia Siddiqui5,Prakhar Srivastava6,Bethany Chung7,Molly Dineen8,Cariosa Devlin8,Claire Worrall1
1University of Oxford,2Oxford University hospitals,3Macmillan,4Oxford University Hospitals,5University of Cambridge,6University of Manchester,7Kings College London,8University of Exeter

Serum biomarkers of iron status and risk of primary liver cancer: A systematic review and meta-analysis.

Year:

Session type:

Kim Tu Tran1,Helen Coleman1,Robert McCain1,Chris Cardwell1
1Queen's University Belfast

Support needs and experiences of people living with advanced incurable cancer

Year:

Session type:

Florien Boele1,Clare Harley1,Simon Pini1,Lucille Kenyon1,Amrit Daffu-O'Reilly1,Galina Velikova1
1University of Leeds

Discovery of prognostic biomarkers from the prostate cancer membrane proteome using bioorthogonal chemistry.

Year:

Session type:

Lynn Asante-Asare1,Mike Deery2,Renata Feret2,Yagnesh Umrania2,Jodi Miller1,Cara Brodie1,Jo Arnold1,André Neves1,Kevin Brindle1
1Cancer Research UK Cambridge Institute,2Cambridge Centre for Proteomics

Polyphenols Enhance the Activity of Alkylating Agents in Leukaemia Cell Lines

Year:

Session type:

Amani Mahbub1,Dr Nicola Jordan-Mahy2,Prof Christine Le Maitre2,Neil Cross2,Sarah Haywood-Small2
1Umm Al Qura University,2Biomolecular Sciences Research Centre, Sheffield Hallam University

Management of Patients with Confirmed Cancer of Unknown Primary: Our Experience

Year:

Session type:

Loaie El-Helw1,Sarah Kelt2,Caroline Connolly2,Karthik Kalyanasundaram2,Nicola Lane2,Ola Stankiewicz2,Lorraine Duke2,Tracey Harrison2,Victoria Bateman2,Joanne Harrison2
1Royal Stoke Hospital, UK and Mansoura University, Egypt,2UHNM

Multifaceted Approach to Improve Care of Oncology Inpatients with Stage 2/3 Acute Kidney Injury: Quality Improvement Project.

Year:

Session type:

Zhong wei Khor1,Tamer Al-Sayed1,Joanne Wooley1,Aisling Walsh1,Katerina Pearson1,Alexander Garbett1
1The Christie NHS Foundation Trust

CT Scan to Screen for Occult Cancer in Unprovoked Venous Thromboembolism (VTE)

Year:

Session type:

CHUN WAI Wong1,Kelly Lim1,Rachel Garnett1,Harris Khan1,Faisal Solkar1,Shahab Abbas1
1ROYAL STOKE UNIVERSITY HOSPITAL

Invasion by gut bacteria promotes growth in early and late stage colorectal tumour cells

Year:

Session type:

James Robson1,David Qualtrough1,Robin Thorn1
1University of the West of England

The risk of ischemic cerebrovascular disease in head and neck cancer patients after radiotherapy

Year:

Session type:

Suzy Kim1,Jin Yong Lee1,Young Ae Kim2,Young Ho Jung3
1SMG-SNU Boramae Medical Center, Seoul,23National Cancer Control Institute, National Cancer Center, Goyang,3Seoul National University Bundang Hospital, Seongnam

Assessment of the role of the preoperative neutrophil-lymphocyte ratio as a prognostic biomarker in nonmetastatic rectal cancer

Year:

Session type:

Manar Almusarhed1,Osamah Al-Asadi1,Azhar Rizvi1,Anil Hermanad1,Qamar Zaman1,Somnath Mukherjee1,Hany Eldeeb1
1Milton Keynes Universiy Hospital

A mixed methods study investigating the effects of a home-based exercise programme on functional outcomes and quality of life in patients with breast cancer undergoing (neo) adjuvant chemotherapy.

Year:

Session type:

Alison Kelly1
1Queen Margaret University, Edinburgh

Roles of EZH2 and KDM6B during EMT

Year:

Session type:

Camille Lachat1,Amandine Etcheverry2,Marc Aubry2,Jean Mosser2,Michael Herfs3,Jean-Paul Feugeas4,Michael Boyer-Guittaut4,Paul Peixoto5,Eric Hervouet5
1INSERM UMR1098,2CHU Rennes, Service de Génétique Moléculaire et Génomique, Rennes F-35033, France ; CNRS, UMR 6290, Institut de Génétique et Développement de Rennes (IGDR), Rennes F-35043, France ; Université Rennes1, UEB, UMS 3480 Biosit, Faculté de Médecine, Rennes F-35043, France ; Plate-forme Génomique Environnementale et Humaine Biosit, Université Rennes1, Rennes F-35043, France,3Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium,4Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France,5Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France ; EPIGENEXP Platform, University of Bourgogne Franche-Comté, F-25000 Besançon, France

Predictive risk factors of venousthromboembolism (VTE) associated withperipherally inserted central catheters(PICC) in ambulant solid cancer patients:retrospective single Centre cohort study

Year:

Session type:

Osamah al-asadi1
1nhs

Can people living with and beyond colorectal cancer make lifestyle changes with the support of health technology?

Year:

Session type:

Victoria Aubrey1,Clare Shaw2
1The Royal Marsden NHS Foundation Trust,2Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London and Sutton

Collaboratively assessing the impact of patient and public involvement in research

Year:

Session type:

Sarah Stapleton1,Martin Lee2
1Royal Marsden Hospital and Institute of Cancer Research,2Royal Marsden and Institute of Cancer Research

The effect of combined FOLFOX with metformin in colorectal cancer cell

Year:

Session type:

Jaw Yuan Wang1,Jaw Yuan Wang2
1Kaohsiung Medical University Hospital, Kaohsiung Medical University,2Kaohsiung Medical University and Hospital

Comparison of dosimetry from bowel bag and individual bowel loop contouring for patients receiving pelvic Stereotactic Ablative Radiotherapy (SABR) radiotherapy

Year:

Session type:

Rhiannon Howells1,Eleanor Clarke1,Matthew Beasley2,Louise Murray3
1University of Leeds,2Leeds Cancer Centre,3Leeds Cancer Centre, University of Leeds

CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples

Year:

Session type:

Xiaolu Zhang1,Silvano Garnerone1,Michele Simonetti1,Marcin Nicoś1,Luuk Harbers1,Caterina Marchiò2,Reza Mirzazadeh1,Tiziana Venesio2,Anna Sapino2,Johan Hartman1,Magda Bienko1,Nicola Crosetto1
1Karolinska Institutet,2Candiolo Cancer Institute

Predicting risk of early relapse with circulating tumour DNA for advanced ER+ breast cancer patients in the PALOMA-3 trial

Year:

Session type:

Ben O'Leary1,Rosalind Cutts1,Xin Huang2,Sarah Hrebien1,Yuan Liu2,Isaac Garcia-Murillas1,Fabrice Andre3,Sibylle Loibl4,Sherene Loi5,Massimo Cristofanilli6,Cynthia Huang Bartlett7,Nicholas Turner1
1The Institute of Cancer Research,2Pfizer,3Institut Gustave Roussy,4German Breast Group,5University of Melbourne,6Robert Lurie Cancer Centre,7Merck

Identification of breast cancer predisposition genes through integration of tumour sequencing and case-control analyses

Year:

Session type:

Ian Campbell1,Na Li1,Belle Lim1,Simone McInerny1,Magnus Zethoven1,Dane Cheasley1,Paul James1
1Peter MacCallum Cancer Centre

Patient, clinicians and trial staff views on the online collection of patient-reported adverse events (AEs) in Early Phase Clinical Trials (EPCT): Phase 1 of the ePRIME study

Year:

Session type:

Fiona Kennedy1,Leanne Shearsmith1,Kathryn Gordon1,Julie Croft2,Sarah Danson3,Julia Brown2,ɢalina Velikova2
1University of Leeds,2University of ʟeeds,3University of Sheffield

DEVELOPING INTERNATIONAL STANDARDS AND RECOMMENDATIONS FOR THE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE DATA

Year:

Session type:

The SISAQOL Consortium (group authorship)1,Madeline Pe2
1Group authorship (multiple),2EORTC

Decision regret in men living with and beyond non-metastatic prostate cancer in the UK: Results from the Life After Prostate Diagnosis study

Year:

Session type:

Sarah Wilding1,Amy Downing1,Peter Selby1,William Cross2,Penny Wright1,Eila K Watson3,Richard Wagland4,Paul Kind1,David W Donnelly5,Luke Hounsome6,Rebecca Mottram1,Majorie Allen1,Therese Kearney5,Hugh Butcher1,Anna Gavin5,Adam W Glaser1
1University of Leeds,2Leeds Teaching Hospitals,3Oxford Brookes University,4University of Southampton,5Queen's University Belfast,6Public Health England

Longitudinal Changes in Fasting Blood Glucose and Cancer Risk in Chinese Population Without Diabetes

Year:

Session type:

Xiaoshuang Feng1,Gang Wang2,Zhangyan Lyu1,Shuohua Chen3,Luopei Wei1,Xin Li1,Yan Wen1,Yuheng Chen1,Shuanghua Xie1,Hong Cui1,Hongda Chen1,Jiang Li1,Chunqing Lin1,Jiansong Ren1,Jufang Shi1,Shouling Wu4,Min Dai1,Ni Li1,Jie He1
1National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,2Kailuan general hospital,3Health department of Kailuan Group,4Health Department of Kailuan Group

Investigating the importance of BCL-3/β-catenin signalling in colorectal tumorigenesis

Year:

Session type:

Penny Timms1,Danny Legge1,Tracey Collard1,Adam Chambers1,Ann Williams1
1University of Bristol

Elevated Parkinson’s-like tumour signalling from very early-stage colorectal cancer is associated with disease relapse

Year:

Session type:

Aoife McCooey1,Keara Redmond1,Emma Kerr1,Daniel Longley1,Philip Dunne1,S-cort Consortium2
1Queen's University Belfast,2S:CORT Consortium

PARP inhibition elicits tumour cell-intrinsic immune phenotypes in DNA repair deficient cancers.

Year:

Session type:

Roman Chabanon1,Gareth Muirhead2,Dragomir Krastev2,Julien Adam1,Marlène Garrido1,Daphné Morel1,Nicolas Dorvault1,Rebecca Marlow3,Alan Ashworth4,Stephen Pettitt2,Syed Haider2,Andrew Tutt2,Aurélien Marabelle1,Jean-Charles Soria5,Christopher Lord2,Sophie Postel-Vinay1
1Gustave Roussy,2Institute of Cancer Research,3King's College London,4UCSF Helen Diller Family Comprehensive Cancer Centre,5AstraZeneca/MedImmune